Literature DB >> 7062743

Androstenedione metabolism by human lymphocytes.

L Milewich, M G Whisenant, M K Sawyer.   

Abstract

Intact human lymphocytes were incubated with tritium-labeled androstenedione; after extraction and appropriate chromatographic separation, followed by crystallization to constant tritium to carbon-14 ratio to establish radiochemical homogeneity, the following metabolites were identified: testosterone, 5 alpha-androstane-3,17-dione, 5 alpha-dihydrotestosterone, androsterone and isoandrosterone. Neither estrogen nor 5 beta-reduced metabolites were found as products. The major androstenedione metabolizing activities in human lymphocytes were 5 alpha-reductase and 17 beta-hydroxysteroid oxidoreductase; in addition, 3 alpha-and 3 beta-hydroxysteroid oxidoreductase activities also were present in these cells. The rates of metabolite formation were linear with incubation time up to 4 h, and with cell number up to 2 x 10(7) lymphocytes per ml for the 5 alpha-reduced products and up to 1.6 x 10(7) lymphocytes per ml for testosterone. These findings are suggestive that, in the human, lymphocytes are a potential site of peripheral metabolism of androstenedione to potent adnrogens.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7062743     DOI: 10.1016/0022-4731(82)90147-9

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  2 in total

1.  Testosterone accumulation in prostate cancer cells is enhanced by facilitated diffusion.

Authors:  Arja Kaipainen; Ailin Zhang; Rui M Gil da Costa; Jared Lucas; Brett Marck; Alvin M Matsumoto; Colm Morrissey; Lawrence D True; Elahe A Mostaghel; Peter S Nelson
Journal:  Prostate       Date:  2019-08-02       Impact factor: 4.104

2.  Short-term and long-term effects of estrogen on lymphoid tissues and lymphoid cells with some remarks on the significance for carcinogenesis.

Authors:  J G Forsberg
Journal:  Arch Toxicol       Date:  1984-07       Impact factor: 5.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.